Literature DB >> 8812495

Structural organization of the human PON1 gene.

J B Clendenning1, R Humbert, E D Green, C Wood, D Traver, C E Furlong.   

Abstract

Serum paraoxonase/arylesterase (PON) is an "A" esterase found in the HDL2 fraction of mammalian sera closely associated with apolipoproteins A1 and J. This enzyme hydrolyzes the active metabolites (oxons) of several organophosphate (OP) insecticides as well as the P-F bond of the nerve agents soman and sarin. PON also destroys biologically active, multioxygenated phospholipids. Two factors result in large individual variations in PON serum levels, a substrate-dependent activity polymorphism and large individual differences in PON protein levels that are stable over time. Animal model studies indicate that PON activity levels are likely to play a major role in determining sensitivity to OPs. The arg192 PON isoform appears to be a risk factor in coronary artery disease. We report here the characterization of a 28-kb contig encompassing 300 bp of 5' sequence, the entire coding region, and 2 kb of 3'-flanking sequence of the PON gene. The structural portion of the paraoxonase protein is encoded by nine exons that form the primary transcript through the use of typical splice donor and acceptor sites. DNA sequences of the regions surrounding all the coding exons have been determined. A polymorphic CA repeat is located in intron 4.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8812495     DOI: 10.1006/geno.1996.0401

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  14 in total

Review 1.  Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease.

Authors:  Daniel Seung Kim; Judit Marsillach; Clement E Furlong; Gail P Jarvik
Journal:  Pharmacogenomics       Date:  2013-09       Impact factor: 2.533

Review 2.  Genetic markers of oxidative stress and coronary atherosclerosis.

Authors:  Nageswara R Madamanchi; Igor Tchivilev; Marschall Runge
Journal:  Curr Atheroscler Rep       Date:  2006-05       Impact factor: 5.113

3.  Paraoxonases-1, -2 and -3: What are their functions?

Authors:  Clement E Furlong; Judit Marsillach; Gail P Jarvik; Lucio G Costa
Journal:  Chem Biol Interact       Date:  2016-05-26       Impact factor: 5.192

Review 4.  Human paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological roles.

Authors:  Mike Mackness; Bharti Mackness
Journal:  Gene       Date:  2015-05-09       Impact factor: 3.688

Review 5.  The Relationship between Cancer and Paraoxonase 1.

Authors:  Irma Martha Medina-Díaz; Néstor Ponce-Ruíz; Aurora Elizabeth Rojas-García; José Francisco Zambrano-Zargoza; Yael Y Bernal-Hernández; Cyndia Azucena González-Arias; Briscia S Barrón-Vivanco; José Francisco Herrera-Moreno
Journal:  Antioxidants (Basel)       Date:  2022-03-31

6.  Paraoxonase: Its antiatherogenic role in chronic renal failure.

Authors:  M Prakash; N M Phani; R Kavya; M Supriya
Journal:  Indian J Nephrol       Date:  2010-01

7.  Aspirin and clopidogrel high on-treatment platelet reactivity and genetic predictors in peripheral arterial disease.

Authors:  Khung-Keong Yeo; Ehrin J Armstrong; Javier E López; Debbie C Chen; Gregory G Westin; Chin-Shang Li; David Anderson; Amy Hua; Anil Singapuri; Ezra A Amsterdam; Nipavan Chiamvimonvat; John R Laird
Journal:  Catheter Cardiovasc Interv       Date:  2018-02-07       Impact factor: 2.692

Review 8.  The Relevance of Noncoding DNA Variations of Paraoxonase Gene Cluster in Atherosclerosis-Related Diseases.

Authors:  Anna Wysocka; Agnieszka Zwolak
Journal:  Int J Mol Sci       Date:  2021-02-21       Impact factor: 5.923

9.  Molecular haplotyping by linking emulsion PCR: analysis of paraoxonase 1 haplotypes and phenotypes.

Authors:  James G Wetmur; Madhu Kumar; Li Zhang; Caroline Palomeque; Sylvan Wallenstein; Jia Chen
Journal:  Nucleic Acids Res       Date:  2005-05-10       Impact factor: 16.971

10.  Increased influence of genetic variation on PON1 activity in neonates.

Authors:  Jia Chen; Madhu Kumar; Wendy Chan; Gertrud Berkowitz; James G Wetmur
Journal:  Environ Health Perspect       Date:  2003-08       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.